To determine whether ME2 promotes PMT of glioma cells, we performed a western blot assay to detect the expression of MES markers MET, YKL40, N-cadherin, and vimentin; epithelial marker E-cadherin; and PN marker OLIG2. The gene discussed is VIM; the disease is central nervous system cancer.